Abstract
Routine estimation of serum phenytoin levels in patients newly admitted to a Special Centre for Epilepsy showed that 40% of those receiving sulthiame in addition to phenytoin had levels in the toxic range. Four long-stay patients became drug intoxicated when sulthiame treatment was started. Sulthiame appears to inhibit the hepatic hydroxylation of phenytoin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BUCHTHAL F., SVENSMARK O., SCHILLER P. J. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960 Jun;2:624–630. doi: 10.1001/archneur.1960.03840120030004. [DOI] [PubMed] [Google Scholar]
- GORDON N. THE USE OF OSPOLOT IN THE TREATMENT OF EPILEPSY. Epilepsia. 1964 Mar;5:68–73. doi: 10.1111/j.1528-1157.1964.tb04347.x. [DOI] [PubMed] [Google Scholar]
- Hansen J. M., Kristensen M., Skovsted L. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism. Epilepsia. 1968 Mar;9(1):17–22. doi: 10.1111/j.1528-1157.1968.tb04954.x. [DOI] [PubMed] [Google Scholar]
- Houghton G. W., Latham A. N., Richens A. Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold. Eur J Clin Pharmacol. 1973 Jun;6(1):57–60. doi: 10.1007/BF00561802. [DOI] [PubMed] [Google Scholar]
- Kutt H., Winters W., McDowell F. H. Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology. 1966 Jun;16(6):594–602. doi: 10.1212/wnl.16.6.594. [DOI] [PubMed] [Google Scholar]
- Olesen O. V., Jensen O. N. Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy. Dan Med Bull. 1969 May;16(5):154–158. [PubMed] [Google Scholar]